Account
News
07.10.2020
Revisiting the influence of ICER in the US

ICER’s Health Technology Assessments review process is an assessment undertaken by one of three ap...

Read more
Articles
29.07.2020
Real world data included in NICE

How has the data available within NCRAS been utilized within the CDF overseen by NICE, in partnershi...

Read more
Articles
11.06.2020
What is real-world evidence

Real-world evidence refers to clinical and economic evidence which has been derived from the analysi...

Read more
Articles
08.01.2020
Greater access to medicines in the UK

NHS England is developing a new Commercial Framework, outlining potential opportunities for commerci...

Read more
Articles
05.12.2016
Theory of multiple criteria decision analysis

Multi-criteria decision analysis (MCDA) is a potentially useful tool that can be used to support dec...

Read more
Articles
08.09.2015
The rise of speciality products

It is the responsibility of CCGs to manage their local drug budgets

Read more
Articles
24.07.2015
Cancer Drug Fund remit

The proposal states that the CDF should become a "managed access" fund for new cancer dugs, with cle...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.